Literature DB >> 20039187

Investigation of pathological and clinical features of lupus nephritis in 73 autopsied cases with systemic lupus erythematosus.

Takayuki Kon1, Ken Yamaji, Kaoru Sugimoto, Michihiro Ogasawara, Kazuo Kenpe, Hitoshi Ogasawara, Kwang-Seok Yang, Hiroshi Tsuda, Toshiharu Matsumoto, Hiroshi Hashimoto, Yoshinari Takasaki.   

Abstract

The aims of this study were to analyze the clinical and pathological features of lupus nephritis (LN) and examine the association between these features and pathological condition, treatment, and prognosis. Of the 177 systemic lupus erythematosus patients who died while receiving inpatient care at Juntendo University Hospital between 1960 and 2001, we investigated the clinical features, treatment, and pathological features of 73 of these who underwent pathological autopsy and had a clear medical history. We divided these cases into two groups, i.e., those up to 1979 (Group A) and those during and after 1980 (Group B) in order to investigate changes in tendencies by age. We also divided the cases into three groups by time interval between diagnosis and death to investigate long-term prognosis. Uremia was the direct cause of death in 38.9% of cases in Group A and only 10.8% of cases in Group B. Pathological features showed a tendency to change to a sclerotic lesion as the duration of the disorder became longer. Uremia attributable to LN was the direct cause of death in relatively fewer cases, although it is still found in the majority of LN cases and remains a problem requiring stringent management. The treatment of sclerotic lesions may be an issue that needs further attention.

Entities:  

Mesh:

Year:  2009        PMID: 20039187     DOI: 10.1007/s10165-009-0260-3

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

Review 1.  Lupus nephritis in Colombians: contrasts and comparisons with other populations.

Authors:  Juan-Manuel Anaya; Carlos Cañas; Rubén D Mantilla; Ricardo Pineda-Tamayo; Gabriel J Tobón; Catalina Herrera-Diaz; Diego M Rendón; Adriana Rojas-Villarraga; Mauricio Uribe
Journal:  Clin Rev Allergy Immunol       Date:  2011-06       Impact factor: 8.667

2.  Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.

Authors:  Hidetoshi Kagawa; Tsutomu Hiromasa; Takayuki Hara; Ayako Takaki; Ryutaro Yamanaka; Ken-ei Sada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2012-04-11       Impact factor: 2.617

3.  Measuring eosinophiluria, urinary eosinophil cationic protein and urinary interleukin-5 in patients with Lupus Nephritis.

Authors:  Tereza Neuma Souza Brito; Maria José Vilar; José Bruno Almeida; Ana Luiza Souza Brito Faria; Sarah Dantas Viana Medeiros; Maria Carmo Cardoso Medeiros; Edna Marques Araújo Silva; Vanessa Marques Araújo Silva; Luanda Bárbara F Canário Souza; Luisa Karla P Arruda; Tatiana Xavier Costa; Geraldo Barroso Cavalcanti Junior; Antonio G Oliveira; Valéria Soraya Farias Sales
Journal:  Allergy Asthma Clin Immunol       Date:  2014-12-12       Impact factor: 3.406

4.  The safety and efficacy of biologic agents in treatment of systemic lupus erythematosus: A network meta-analysis.

Authors:  Meng-Jun Tao; Ping Cheng; Lai-Run Jin; Jun Zhou; Wei Shi; Hui Peng; Liang Xu; Zhi Li; Hui Yuan
Journal:  Pak J Med Sci       Date:  2019 Nov-Dec       Impact factor: 1.088

Review 5.  Mechanism of Action and Efficacy of Immunosupressors in Lupus Nephritis.

Authors:  Mario E Alamilla-Sanchez; Miguel A Alcala-Salgado; Cesar D Alonso-Bello; Gandhy T Fonseca-Gonzalez
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-12-11

6.  Very delayed lupus nephritis: a report of three cases and literature review.

Authors:  André R Alexandre; Pedro L Carreira; David A Isenberg
Journal:  Lupus Sci Med       Date:  2018-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.